• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[绝经后女性的激素替代疗法与心血管风险]

[Hormone replacement therapy in postmenopausal women and cardiovascular risk].

作者信息

Karam C, Bourmayan C, Desnos M, Guérot C

机构信息

Service de Cardiologie, Hôpital Boucicaut, Paris.

出版信息

Ann Cardiol Angeiol (Paris). 1995 Apr;44(4):195-201.

PMID:7632028
Abstract

Although the cardiovascular effects of hormone replacement therapy of menopause have been controversial for a long time, the benefit of this treatment currently appears to be well established, despite the methodological problems of most studies and the absence of definitive demonstration by a prospective randomized study. The mechanism of this favourable action appears to be multifactorial with, in particular, an improvement of the lipid profile. In the absence of any gynaecological contraindication, the combination of a natural oestrogen and a progestogen devoid of any androgenic effect therefore appears to be the preferable treatment in postmenopausal women, especially as its cardiological value is added to other important and clearly documented actions.

摘要

尽管更年期激素替代疗法的心血管效应长期以来一直存在争议,但尽管大多数研究存在方法学问题且缺乏前瞻性随机研究的确切证明,但目前这种治疗的益处似乎已得到充分证实。这种有利作用的机制似乎是多因素的,特别是脂质谱得到改善。因此,在没有任何妇科禁忌证的情况下,天然雌激素和无任何雄激素作用的孕激素联合使用似乎是绝经后女性的首选治疗方法,尤其是因为其心脏保护价值是在其他重要且有明确记录的作用之上的。

相似文献

1
[Hormone replacement therapy in postmenopausal women and cardiovascular risk].[绝经后女性的激素替代疗法与心血管风险]
Ann Cardiol Angeiol (Paris). 1995 Apr;44(4):195-201.
2
Comparative cardiovascular effects of different progestins in menopause.不同孕激素在绝经后对心血管系统的比较影响
Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56.
3
[Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
J Gynecol Obstet Biol Reprod (Paris). 1996;25(7):671-6.
4
[Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].[激素替代疗法的生物学及实际应用:绝经后女性心血管疾病预防策略]
Rev Port Cardiol. 1999 Nov;18(11):1047-55.
5
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.接受雌激素替代疗法的绝经后女性中具有不同雄激素活性和心血管危险因素的孕激素
Clin Endocrinol (Oxf). 2004 Dec;61(6):760-7. doi: 10.1111/j.1365-2265.2004.02166.x.
6
Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.激素替代疗法与心脏保护:新的曙光?意大利心脏病学会女性心血管疾病研究小组关于绝经后女性激素替代疗法的声明
J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.
7
Postmenopausal hormone therapy and the risk of cardiovascular disease.绝经后激素治疗与心血管疾病风险
J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):303-9. doi: 10.2459/JCM.0b013e328324991c.
8
[Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].[绝经后女性的激素补充剂:无预防心血管疾病的证据]
Ned Tijdschr Geneeskd. 2001 Jan 13;145(2):61-4.
9
[Hormone replacement therapy and cardiovascular risk in menopausal women].[激素替代疗法与绝经后女性的心血管风险]
Arch Mal Coeur Vaiss. 2001 Feb;94(2):132-8.
10
[Hormone replacement therapy and cardiovascular risk in postmenopausal women].[激素替代疗法与绝经后女性的心血管风险]
Med Pregl. 2009;62 Suppl 3:85-90.